|
Apr 1, 2012
By:
Ben Comer
What does a Scottish vote for independence mean for Big Pharma investment and healthcare funding and delivery in the UK?
|
|
Mar 7, 2012
By:
Jennifer Ringler, Ben Comer
Jim Currie and Baber Ghauri talk to Pharm Exec about making connections that resonate with audiences in a digital world.
|
|
Mar 1, 2012
By:
Ben Comer
In the rush to collect as much patient data as possible, are we sacrificing quality for quantity? Ben Comer reports.
|
Mar 1, 2012
By:
Jennifer Ringler, Ben Comer
Making real connections that resonate with audiences in a digital world is a fine art, especially in the heavily regulated world of Big Pharma
|
Feb 1, 2012
By:
Ben Comer
Pharm Exec's Brand of the Year: Abbott's Humira
|
|
Feb 1, 2012
By:
Ben Comer
Rich data on the clinical side, combined with flexible marketing and outreach to payers, have pushed Humira to the top ranks of powerhouse drugs...
|
Feb 1, 2012
By:
Ben Comer
Pharm Exec speaks to Bausch + Lomb CEO Brent Saunders about how he turned around "a very troubled company".
|
|
Jan 1, 2012
By:
Ben Comer
A selection of the recent breakthrough technologies showcased at the Cleveland Clinic's Medical Innovations Summit.
|
Dec 1, 2011
By:
Ben Comer
Patients want to take a more active role in treatment decisions. Drug facts boxes in DTC ads represent a crucial element of informed consent.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
